Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
1.01.
|
Entry
Into a Material Definitive
Agreement.
|
Item
8.01.
|
Other
Events
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit
Number
|
Description
|
10.1
|
Employment
Agreement, dated as of July 14, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Rakesh Soni.
|
99
|
Press
Release
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By:
|
/s/
Chang H. Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive Officer
|
Exhibit
Number
|
Description
|
Employment
Agreement, dated as of July 14, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Rakesh Soni
|
|
Press
Release
|